Early Human Cytomegalovirus Reactivation Is Associated With Lower Incidence of Relapse of Myeloproliferative Disorders After Allogeneic Hematopoietic Stem Cell Transplantation
Researchers studying cytomegalovirus (CMV) and myeloproliferative disorders found that a substantial reduction in relapse of myeloproliferative disorders is associated with CMV reactivation after allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Bone Marrow Transplantation
In The News
American Journal of Managed Care
In The Literature
American Journal of Hematology European Journal of Haematology